The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,748.00
Bid: 3,746.00
Ask: 3,750.00
Change: 38.00 (1.02%)
Spread: 4.00 (0.107%)
Open: 3,730.00
High: 3,764.00
Low: 3,706.00
Prev. Close: 3,710.00
DPLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

20 Jan 2021 07:00

RNS Number : 2115M
Diploma PLC
20 January 2021
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

20 January 2021

 

 

DIPLOMA PLC

 

 

FIRST QUARTER TRADING UPDATE

 

STRONG TRADING AND THREE HIGH QUALITY BOLT-ON ACQUISITIONS IN Q1

 

Diploma PLC, the international group supplying specialised products and services, is today issuing its first quarter trading update in respect of the year ending 30 September 2021, ahead of the Company's closed door AGM today at 12.00, midday.

 

 

Group

 

Diploma has made a strong start to the year with improved trends in underlying trading across all of the Group's three Sectors in the first quarter. The Group delivered underlying revenues in line with last year's pre-Covid comparative, reflecting strong execution of our organic growth initiatives. Reported Group revenues in the first quarter ended 31 December 2020 increased by 24% over the comparable period, driven by an excellent first quarter contribution from Windy City Wire (WCW) which is trading very well following a smooth transition into the Group.

 

The following table sets out the year-on-year revenue performance by Sector for Q1 alongside a reminder of the exit rates reported for September 2020:

 

Sector performance

Q1

Sept 20

Life Sciences

Underlying

+8%

+2%

 

Reported

+10%

 

 

 

 

 

Seals

Underlying

-2%

-4%

 

Reported

-0%

 

 

 

 

 

Controls

Underlying

-1%

-18%

 

Reported

+71%

 

 

 

 

 

Group

Underlying

+0%

-7%

 

Reported

+24%

 

 

 

Life Sciences

 

Life Sciences delivered strong underlying growth of 8%, driven by an encouraging performance in consumables in both clinical diagnostics and specialty surgical equipment in Australia and Canada, as well as higher than normal levels of capital installations due to pent up demand from last year's lockdowns. In Q2, we expect growth rates to moderate with lockdowns in Canada impacting capital sales and surgical procedures. However, the Sector remains well positioned to capitalise on the backlog of surgical procedures and lab testing as the year progresses.

 

 

Seals

 

Seals traded well with underlying revenues improving to -2%. The Group continues to see strong performances from International Seals due to the diversity of end markets and North American Aftermarket due to continued strong repair shop demand. The North American OEM business has been recovering well in the last two quarters, and we are confident in its prospects under a strengthened management team. The transition to the new Aftermarket automated facility in Louisville has completed successfully and will support future market share gains.

 

 

Controls

 

Underlying revenues have seen a strong recovery since the start of year, improving to -1% reflecting the execution of initiatives to diversify the Sector's revenue streams. Reported revenues were up 71% due to the contribution from WCW. After a smooth transition into the Group WCW is trading very well, growing both revenues and profits broadly in line with their impressive track record and ahead of our initial expectations. Some benefits from Brexit inventory build in Q1 are likely to unwind in the coming weeks and, along with the impact of further UK lockdowns, may impact Q2 trading in Controls. However, the Sector's healthier revenue profile will underpin a return to growth this year.

 

 

Acquisitions

 

Bolt-on acquisitions remain a core part of the Group's strategy. The first quarter has been active with £48.8m invested in three high quality, strategically important bolt-on acquisitions to build scale in core markets and enhance our organic growth ambitions:

 

· Simonsen & Weel (annualised revenues ca.£25m), an excellent Healthcare business based in Denmark and building the Life Sciences Sector's presence in Northern Europe;

· FITT Resources (annualised revenues ca.£13m), a well established, high quality Seals business that significantly strengthens the Sector's footprint in Eastern Australia; and

· Power Dynamics (annualised revenues ca.£5m), a gasket bolt-on for VSP within our NA Seals business, expanding VSP's presence across the Northern US.

 

 

Financial position

 

As previously stated, the Group's equity raise in September 2020 allowed Diploma to retain balance sheet flexibility following the acquisition of WCW. This has enabled the Group to pursue its bolt-on acquisition strategy while maintaining a strong financial position. After three bolt-on acquisitions in Q1, net debt at year-end is expected to be at around 1.2x EBITDA.

 

 

Outlook

 

Inevitably uncertainties remain with respect to the duration and impact of the Covid-19 pandemic. However, while the pandemic may modestly affect Q2 revenues, we are pleased with the Group's trading performance. Excluding the contribution from the acquisitions completed in the quarter, full year expectations for the underlying business remain positive and unchanged. 

 

 

Enquiries:

 

Diploma PLC -

Johnny Thomson, Chief Executive Officer

+44 (0)20 7549 5700

Barbara Gibbes, Chief Financial Officer

 

 

 

 

 

Tulchan Communications -

+44 (0)20 7353 4200

Martin Robinson

 

Olivia Peters

 

 

 

 

 

 

Notes:

 

1. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Diploma PLC. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. All references in this Statement to "underlying" revenues refer to reported results on a constant currency basis and before any contribution from acquired or disposed businesses.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

 

 

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUGUGUPGGAB
Date   Source Headline
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding
11th Dec 201511:38 amRNSDirector/PDMR Shareholding
9th Dec 20154:00 pmRNSAnnual Financial Report and Notice of AGM
30th Nov 201510:00 amRNSHolding(s) in Company
17th Nov 201510:00 amRNSDirectorate Change
16th Nov 20157:00 amRNSFinal Results
27th Oct 201512:10 pmRNSHolding(s) in Company
30th Sep 20159:31 amRNSDirector/PDMR Shareholding
25th Sep 201510:01 amRNSDirector/PDMR Shareholding
24th Sep 20159:12 amRNSHolding(s) in Company
24th Sep 20159:00 amRNSHolding(s) in Company
23rd Sep 20154:50 pmRNSDirector/PDMR Shareholding
14th Sep 201511:43 amRNSHolding(s) in Company
8th Sep 20157:00 amRNSDirectorate Changes
3rd Sep 20153:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20157:02 amRNSDirectorate Change
2nd Sep 20157:00 amRNSTrading Update
24th Aug 20159:47 amRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Jul 20157:00 amRNSNotice of Trading Update
5th Jun 201511:00 amRNSDirector Declaration
14th May 20154:00 pmRNSDirector/PDMR Shareholding
11th May 20157:00 amRNSInterim Management Statement
31st Mar 201510:04 amRNSDirector/PDMR Shareholding
30th Mar 20157:00 amRNSTrading Statement
13th Mar 20157:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.